Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MOHAMMAD FAYEZ B RUJUBALI

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1306068234
CMS profile
940610
Location
HICKORY, NC

General Payments · PY2018–2024

$6,859.30

  • Reported across 173 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,871.01

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Education $1,599.95 2
Food and Beverage $271.06 14

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $475.17 20
PY2019 $970.65 36
PY2020 $244.41 8
PY2021 $260.28 15
PY2022 $797.23 32
PY2023 $2,240.55 46
PY2024 $1,871.01 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ANI Pharmaceuticals, Inc. $14.86 04/09/2024 Food and Beverage Undisputed 01/23/2026 1091161736 CMS
ANI Pharmaceuticals, Inc. $16.97 05/31/2024 Food and Beverage Undisputed 01/23/2026 1091151420 CMS
ANI Pharmaceuticals, Inc. $17.02 09/18/2024 Food and Beverage Undisputed 01/23/2026 1091172286 CMS
ANI Pharmaceuticals, Inc. $22.31 12/05/2024 Food and Beverage Undisputed 01/23/2026 1091158796 CMS
AstraZeneca Pharmaceuticals LP $18.71 03/05/2024 Food and Beverage Undisputed 01/23/2026 1104280771 CMS
AstraZeneca Pharmaceuticals LP $19.70 03/12/2024 Food and Beverage Undisputed 01/23/2026 1105454091 CMS
AstraZeneca Pharmaceuticals LP $19.05 03/27/2024 Food and Beverage Undisputed 01/23/2026 1104741935 CMS
AstraZeneca Pharmaceuticals LP $21.95 10/24/2024 Food and Beverage Undisputed 01/23/2026 1105694224 CMS
AstraZeneca Pharmaceuticals LP $15.43 10/30/2024 Food and Beverage Undisputed 01/23/2026 1104207523 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $23.72 08/15/2024 Food and Beverage Undisputed 01/23/2026 1117954853 CMS
Electromed, Inc. $12.73 01/25/2024 Food and Beverage Undisputed 01/23/2026 1137911763 CMS
Insmed, Inc. $21.18 01/10/2024 Food and Beverage Undisputed 01/23/2026 1089575972 CMS
INTUITIVE SURGICAL, INC. $1,500.00 04/25/2024 Education Undisputed 01/23/2026 1137165946 CMS
Regeneron Healthcare Solutions, Inc. $27.09 04/18/2024 Food and Beverage Undisputed 01/23/2026 1114151094 CMS
Regeneron Healthcare Solutions, Inc. $20.34 11/14/2024 Food and Beverage Undisputed 01/23/2026 1114151096 CMS
SANOFI-AVENTIS U.S. LLC $99.95 10/03/2024 Education Undisputed 01/23/2026 1139720552 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.